Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Klemens Budde(Charité - Universitätsmedizin Berlin), Thomas Becker(Medizinische Hochschule Hannover), Wolfgang Arns(University Hospital Cologne), Claudia Sommerer(Heidelberg University), Petra Reinke(Charité - Universitätsmedizin Berlin), Ute Eisenberger(University of Bern), Stefan Krämer(Novartis (Germany)), Wolfgang Fischer(Novartis (Switzerland)), Harald Gschaidmeier(Novartis (Germany)), Frank Pietruck(University of Duisburg-Essen)
The Lancet
February 20, 2011
Cited by 355

Abstract


Related Papers

No related papers found

Powered by citation graph analysis